Marie-Lou Filiatrault1,2, Jean-Marc Chauny3,4, Raoul Daoust3,4, Marie-Pier Roy1,4, Ronald Denis3,5, Gilles Lavigne1,5,6. 1. Center for Advanced Research in Sleep Medicine, Hôpital du Sacré-Cœur de Montréal, Montreal, Quebec, Canada. 2. Faculty of Graduate and Postdoctoral Studies, Université de Montréal, Montreal, Quebec, Canada. 3. Faculty of Medicine, Université de Montréal, Montreal, Quebec, Canada. 4. Department of Emergency Medicine, Research Center, Hôpital du Sacré-Cœur de Montréal, Montreal, Quebec, Canada. 5. Department of Surgery, Hôpital du Sacré-Coeur de Montreal, Montreal, Quebec, Canada. 6. Faculty of Dental Medicine, Université de Montréal, Montreal, Quebec, Canada.
Abstract
STUDY OBJECTIVE: Opioids are associated with higher risk for ataxic breathing and sleep apnea. We conducted a systematic literature review and meta-analysis to assess the influence of long-term opioid use on the apnea-hypopnea and central apnea indices (AHI and CAI, respectively). METHODS: A systematic review protocol (Cochrane Handbook guidelines) was developed for the search and analysis. We searched Embase, Medline, ACP Journal Club, and Cochrane Database up to November 2014 for three topics: (1) narcotics, (2) sleep apnea, and (3) apnea-hypopnea index. The outcome of interest was the variation in AHI and CAI in opioid users versus non-users. Two reviewers performed the data search and extraction, and disagreements were resolved by discussion. Results were combined by standardized mean difference using a random effect model, and heterogeneity was tested by χ(2) and presented as I(2) statistics. RESULTS: Seven studies met the inclusion criteria, for a total of 803 patients with obstructive sleep apnea (OSA). We compared 2 outcomes: AHI (320 opioid users and 483 non-users) and 790 patients with CAI (315 opioid users and 475 non-users). The absolute effect size for opioid use was a small increased in apnea measured by AHI = 0.25 (95% CI: 0.02-0.49) and a medium for CAI = 0.45 (95% CI: 0.27-0.63). Effect consistency across studies was calculated, showing moderate heterogeneity at I(2) = 59% and 29% for AHI and CAI, respectively. CONCLUSIONS: The meta-analysis results suggest that long-term opioid use in OSA patients has a medium effect on central sleep apnea.
STUDY OBJECTIVE: Opioids are associated with higher risk for ataxic breathing and sleep apnea. We conducted a systematic literature review and meta-analysis to assess the influence of long-term opioid use on the apnea-hypopnea and central apnea indices (AHI and CAI, respectively). METHODS: A systematic review protocol (Cochrane Handbook guidelines) was developed for the search and analysis. We searched Embase, Medline, ACP Journal Club, and Cochrane Database up to November 2014 for three topics: (1) narcotics, (2) sleep apnea, and (3) apnea-hypopnea index. The outcome of interest was the variation in AHI and CAI in opioid users versus non-users. Two reviewers performed the data search and extraction, and disagreements were resolved by discussion. Results were combined by standardized mean difference using a random effect model, and heterogeneity was tested by χ(2) and presented as I(2) statistics. RESULTS: Seven studies met the inclusion criteria, for a total of 803 patients with obstructive sleep apnea (OSA). We compared 2 outcomes: AHI (320 opioid users and 483 non-users) and 790 patients with CAI (315 opioid users and 475 non-users). The absolute effect size for opioid use was a small increased in apnea measured by AHI = 0.25 (95% CI: 0.02-0.49) and a medium for CAI = 0.45 (95% CI: 0.27-0.63). Effect consistency across studies was calculated, showing moderate heterogeneity at I(2) = 59% and 29% for AHI and CAI, respectively. CONCLUSIONS: The meta-analysis results suggest that long-term opioid use in OSA patients has a medium effect on central sleep apnea.
Authors: R Nisha Aurora; Susmita Chowdhuri; Kannan Ramar; Sabin R Bista; Kenneth R Casey; Carin I Lamm; David A Kristo; Jorge M Mallea; James A Rowley; Rochelle S Zak; Sharon L Tracy Journal: Sleep Date: 2012-01-01 Impact factor: 5.849
Authors: Gilles J Lavigne; Alberto Herrero Babiloni; Pierre Mayer; Raoul Daoust; Marc O Martel Journal: J Clin Sleep Med Date: 2020-02-13 Impact factor: 4.062
Authors: Andrew S Tubbs; Sadia B Ghani; Michelle Naps; Michael A Grandner; Michael D Stein; Subhajit Chakravorty Journal: J Clin Sleep Med Date: 2022-03-01 Impact factor: 4.324
Authors: Mary Beth Miller; Wai Sze Chan; Ashley F Curtis; Jeff Boissoneault; Michael Robinson; Roland Staud; Richard B Berry; Christina S McCrae Journal: Sleep Med Date: 2018-09-05 Impact factor: 3.492
Authors: Kevin Chen; Henry K Yaggi; David A Fiellin; Eric C DeRycke; Wardah Athar; Sally Haskell; Lori A Bastian Journal: Pain Date: 2020-09-01 Impact factor: 7.926
Authors: Mary Beth Miller; Ashley F Curtis; Wai Sze Chan; Chelsea B Deroche; Christina S McCrae Journal: J Clin Sleep Med Date: 2021-04-01 Impact factor: 4.324